MotherToBaby

Medications and More during pregnancy and breastfeeding

Search

866.626.6847

Apremilast (Otezla®)

Referencias Seleccionadas:

  • Amgen, Inc. 2023. Otezla product label. https://www.pi.amgen.com/~/media/amgen/repositorysites/pi-amgen-com/otezla/otezla_pi_english.ashx. [Accessed February 2024].
  • Bangsgaard N, et al. 2015 Treating Psoriasis During Pregnancy: safety and efficacy of treatments. Am J Clin Dermatol. 16(5):389-98.
  • Celgene Corporation. 2015. Otezla product label. Accessed April 2020 https://www.pi.amgen.com/~/media/amgen/repositorysites/pi-amgen-com/otezla/otezla_pi_english.ashx
  • Hoffman MB, et al. 2015. Psoriasis during pregnancy: characteristics and important management recommendations. Expert Rev Clin Immunol. 11(6):709-20
  • Kaushik SB, et al. 2019. Psoriasis: Which therapy for which patient: Focus on special populations and chronic infections. J Am Acad Dermatol. 80(1):43-53.
  • Rademaker M,et al. 2018. Psoriasis in those planning a family, pregnant or breast-feeding. The Australasian Psoriasis Collaboration. Australas J Dermatol. 59(2):86-100
  • Saavedra MA, et al. 2018. Targeted drugs in spondyloarthritis during pregnancy and lactation. Pharmacol Res. 136:21-28.

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.